AOL1mon
Novo Nordisk's $600 Million Gambit Could Be a Game Changer for the Stock. Here's Why.
Novo Nordisk (NYSE: NVO) just made a partnership play worth $600 million with a small biotech called NanoVation that might just change the stock's trajectory for many years to come. On Sept.
PMLiVE5d
Novo Nordisk’s GLP-1 drug semaglutide shows promise in fatty liver disease MASH
Novo Nordisk has shared promising results from a late-stage study of semaglutide in patients with metabolic ...
BioWorld1mon
Nanovation Therapeutics partners with Novo Nordisk on genetic medicines for cardiometabolic and rare diseases
Nanovation Therapeutics Inc. has established a multiyear partnership with Novo Nordisk A/S to advance the development of novel genetic medicines targeting cardiometabolic and rare diseases. The ...
PopVax Announces 1.15 Million USD in Funding from the Bill and Melinda Gates Foundation for Thermostable mRNA Delivery Formulation Development
BusinessWire India Mumbai Maharashtra Hyderabad Telangana [India] October 30 PopVax an Indian full-stack biotechnology ...
Business Wire11d
PopVax Announces 1.15 Million USD in Funding from the Bill & Melinda Gates Foundation for Thermostable mRNA Delivery Formulation Development
who previously worked with pioneering nucleic acid delivery research groups at NanoVation Therapeutics and during his PhD at the University of British Columbia in Canada. “We at PopVax are ...
PipelineReview.com9d
PopVax Announces 1.15 Million USD in Funding from the Bill & Melinda Gates Foundation for Thermostable mRNA Delivery Formulation Development
MUMBAI, India & HYDERABAD, India I October 30, 2024 I PopVax, an Indian full-stack biotechnology company developing novel mRNA vaccines and therapeutics ...